Investment Rating - The investment rating for the company is "Buy" [7] Core Views - The recent decline in the company's stock price has already factored in the impairment impact and the market liquidity contraction [1] - The company plans to distribute a final dividend of HKD 0.13 per share for the fiscal year 2025, resulting in a total annual dividend of HKD 0.25 per share, maintaining a dividend payout ratio of 70.2% [1] - The acquisition of Shandong Qinbin Expressway is expected to contribute positively to earnings starting in 2026 [1] Revenue and Profitability - The company reported a revenue of HKD 4.33 billion for the fiscal year 2025, representing a year-on-year increase of 12.0% [11] - The net profit attributable to the parent company was HKD 533 million, a decrease of 18.9% year-on-year [11] - Excluding impairment factors, the company's net profit excluding non-recurring items grew by 8.4% year-on-year to HKD 712 million [1][11] Traffic Revenue Growth - The company's toll revenue increased by 12.2% year-on-year in fiscal year 2025, primarily due to the acquisition of Pinglin Expressway [2] - The Han-Ehu Expressway saw a toll revenue increase of 22% year-on-year, benefiting from the closure and expansion of the Wuhuang Expressway [2] Cost and Margin Analysis - Operating costs increased by 19.6% year-on-year, while gross profit grew by 3.6% [3] - The company adjusted its intangible asset amortization, leading to a rise in costs [3] - Financial expenses decreased by 10.7% year-on-year due to lower market interest rates [3] Acquisition Impact - The acquisition of 85% of Shandong Qinbin Expressway for HKD 1.153 billion is expected to yield an estimated internal rate of return (IRR) of approximately 10.43% [4] - The projected net profits from Qinbin Expressway for 2026 to 2028 are estimated at HKD 124 million, HKD 162 million, and HKD 195 million respectively [4] Earnings Forecast and Valuation - The forecast for net profit attributable to the parent company for 2026 and 2027 has been adjusted to HKD 818 million and HKD 801 million, respectively [5] - The target price has been raised to HKD 5.53 based on a 10x 2026E PE ratio [5] - The estimated dividend yield for 2026 is projected to be 7.8%, indicating strong attractiveness [5]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 65.56 and HKD 49.94 for A/H shares [6]. Core Insights - The company achieved a revenue of RMB 28.703 billion in 2025, representing a year-on-year increase of 15.23%, and a net profit of RMB 4.097 billion, up 10.64% year-on-year. The adjusted net profit was strong at RMB 3.9 billion, reflecting a year-on-year growth of 20.91% [1]. - The report highlights that despite the peak demand in rail transit business, the company is expected to maintain stable orders through maintenance and expansion in various categories such as signaling and power supply [2]. - The semiconductor business continues to show high growth, with a revenue increase of 26.72% year-on-year, and the company has secured significant domestic and international orders in the renewable energy sector [3]. - The forecast for 2026-2028 indicates a revenue growth of RMB 322.28 billion, RMB 367.15 billion, and RMB 415.52 billion, respectively, with net profits projected at RMB 46.33 billion, RMB 51.62 billion, and RMB 58.03 billion [4]. Summary by Sections Revenue and Profitability - In 2025, the company’s rail transit business generated RMB 158.06 billion in revenue, a year-on-year increase of 7.99%. The revenue from various segments includes RMB 121.06 billion from rail transit electrical equipment, RMB 18.99 billion from rail engineering machinery, and RMB 11.49 billion from communication signaling systems [2]. - The emerging equipment business reported a revenue of RMB 127.80 billion, with significant contributions from semiconductors (RMB 55.32 billion), automotive (RMB 32.68 billion), and renewable energy (RMB 24.01 billion) [3]. Forecast and Valuation - The company is expected to benefit from its integrated layout in the semiconductor and emerging business sectors, with projected net profits for 2026 from emerging business and rail transit at RMB 13.3 billion and RMB 33.1 billion, respectively [4][12]. - The valuation analysis suggests a PE ratio of 31.4x for the emerging equipment business and 14.3x for rail transit and other businesses, reflecting a premium based on competitive advantages in the energy demand sector [12].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 22.14 [1][5]. Core Insights - The company's 2025 revenue and net profit are expected to be RMB 364 million and RMB 82.41 million, respectively, reflecting a year-on-year growth of 0.3% and a decline of 38.8% [1]. - The performance in Q4 2025 showed improvement with revenue and net profit increasing by 23.0% and 56.6% year-on-year, indicating a positive trend as the demand for consumer healthcare recovers [1][5]. - The company faces challenges in 2025 due to tax rate adjustments, slow recovery in consumer medical demand, and increased competition in products like oral repair membranes [1][2]. Revenue and Profitability - The oral repair membrane revenue for 2025 is projected at RMB 136 million, down 15.8% year-on-year, with a gross margin of 88.14% [2]. - The new product, active biological bone, has started contributing revenue, achieving sales of RMB 32.15 million by the end of 2025, while the revenue from the membrane products grew by 12.4% year-on-year [3]. - The overall gross margin for 2025 is expected to decline to 85.88%, primarily due to increased market competition and the impact of centralized procurement [4]. Expense and Forecast Adjustments - The company has seen an increase in various expense ratios, with sales, management, and R&D expenses rising significantly [4]. - The profit forecast for 2026-2028 has been adjusted downwards, with expected net profits of RMB 93 million, RMB 103 million, and RMB 115 million, reflecting a year-on-year growth of 12.5%, 11.4%, and 11.1% respectively [5][13]. - The valuation for 2026 is set at 43x PE, compared to the industry average of 33x, indicating a premium valuation based on the company's growth prospects [5][13].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 6.45 [1][5] Core Insights - The company reported a revenue of CNY 24.315 billion for the year 2025, a decrease of 10.0% year-on-year. EBITDA was CNY 3.95 billion, down 16.6%, and net profit attributable to shareholders was CNY 1.262 billion, a decline of 25.1% [1][2] - The decline in revenue was primarily due to a greater-than-expected drop in product prices in the second half of the year, which affected the company's ability to absorb fixed costs [1] - The company has a strong procurement advantage due to recent price recovery trends in upstream raw materials, which is expected to accelerate industry consolidation [1] Summary by Sections Revenue and Sales Performance - In 2025, the company achieved sales volumes of 1.77 million tons for PVC products and 0.72 million tons for non-PVC products, resulting in a total sales volume of 2.49 million tons, a slight increase of 0.45% year-on-year [2] - The average selling price for PVC and non-PVC products decreased by 10.9% and 9.8% respectively, with a significant drop in prices observed in the second half of the year [2] - The total revenue from the plastic pipe business was CNY 20.78 billion, down 8.9% year-on-year [2] Financial Metrics - The company's overall gross margin was 27.49%, an increase of 0.50 percentage points year-on-year, despite the decline in product prices [3] - The financial expense ratio decreased to 2.8%, down 0.7 percentage points, primarily due to a reduction in financial expenses by CNY 270 million [3] - The company reported a significant reduction in accounts receivable, which stood at CNY 3.33 billion, down 15.5% year-on-year, indicating effective control over receivables [4] Dividend and Profitability - The company plans to distribute a cash dividend of HKD 0.02 per share, with a payout ratio of 44.4%, an increase of 10 percentage points from the previous year [4] - The forecast for net profit attributable to shareholders for 2026 is adjusted to CNY 1.607 billion, reflecting a year-on-year increase of 27.35% [5][10] Valuation and Market Comparison - The company is assigned a PE ratio of 11 times for 2026, with a target price adjusted to HKD 6.45, reflecting a valuation discount compared to comparable companies [5][11] - The average PE ratio for comparable companies is 18 times for 2026, indicating a potential upside for the company given its lower valuation [11]

Investment Rating - The investment rating for the company is maintained at "Buy" [1] Core Views - The report expresses optimism about the company's MPO business, which is expected to recover in 2026, driven by the high demand for 800G and 1.6T optical modules [12] - The company is expected to expand its overseas customer base further in 2026, and it continues to focus on innovation and core technology development [6][12] - The report has adjusted the revenue and profit forecasts for 2026-2027 due to the impact of order delivery schedules, with net profits projected at 503 million, 726 million, and 973 million RMB for 2026, 2027, and 2028 respectively [6][9] Financial Data Summary - As of March 31, 2026, the closing price of the company's stock was 107.66 RMB, with a market capitalization of 24,452 million RMB [2] - The company's revenue for 2025 was 1,547 million RMB, representing a year-on-year growth of 12.26%, while the net profit attributable to the parent company was 299 million RMB, up 14.43% [9] - The projected revenues for 2026, 2027, and 2028 are 2,355 million, 3,372 million, and 4,356 million RMB respectively, with growth rates of 52.23%, 43.19%, and 29.20% [5] - The projected net profit for 2026, 2027, and 2028 is expected to be 503 million, 726 million, and 973 million RMB, with respective growth rates of 68.30%, 44.24%, and 34.00% [5][6] - The company's EPS (Earnings Per Share) is projected to be 2.22 RMB in 2026, increasing to 4.28 RMB by 2028 [5] Market Performance - The report indicates that the company's overseas business generated revenue of 1,196 million RMB in 2025, accounting for 77.33% of total revenue, while domestic revenue was 351 million RMB [10] - The overall gross margin for the company improved to 38.00% in 2025, an increase of 2.39 percentage points year-on-year [11]

Investment Rating - The report maintains an investment rating of "Buy" for the company with a target price of RMB 1,824.00 [1][11] Core Insights - The report emphasizes that 2026 is a critical year for the company as it transitions to "market-oriented governance." The market has concerns about the stability of the company's flagship product pricing and long-term growth potential, overlooking the governance benefits from the new management's marketing reforms. In the short term, the price of the flagship product has reached a "L-shaped" bottom, with limited downside risk. In the medium to long term, there is growth potential in both volume and price, and the company's growth path is becoming clearer. The current valuation has dropped to historical lows, and the dividend yield is attractive in a low-interest-rate environment, suggesting a favorable entry point for long-term investment [6][16][19]. Summary by Sections Short-term Perspective - The flagship product's price has significantly decreased, entering a "L-shaped" bottom due to a rapid decline in demand and ongoing supply pressures. The current price level is supported by traditional consumer demand, and the price is now within the purchasing power release range for consumers, indicating limited further downside risk. The upcoming festive season is expected to show strong sales performance, providing support for price stabilization [7][17][24]. Medium-term Perspective - The company is initiating a market-oriented transformation in 2026, focusing on three core elements: product structure, pricing, and channel strategy. The product strategy aims to optimize the pyramid structure, while the channel strategy emphasizes a blend of online and offline sales. The pricing strategy will shift from a dual-track system to a market-responsive approach, enhancing governance capabilities and improving operational quality in the long run [8][18][39]. Long-term Outlook - The company has demonstrated resilience through various market cycles over the past thirty years. Despite current industry adjustments, it possesses superior counter-cyclical measures. Future growth is expected to be driven by volume and price increases, with a compound annual growth rate (CAGR) of approximately 4% for both volume and price. The company is projected to maintain mid-to-high single-digit revenue growth in the medium to long term [9][19][20]. Differentiation from Market Views - The report contrasts with prevailing market concerns regarding the flagship product's price decline, the effectiveness of reforms, and long-term growth potential. It argues that the financial premium has been largely eliminated, and the price is now more stable. The management's proactive approach to market governance is expected to reduce operational risks and activate latent demand. The company retains the flexibility to expand its distribution rights, which will support its growth trajectory [10][21][22].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 375.80 RMB [6]. Core Insights - The company achieved a revenue of 9.203 billion RMB in 2025, representing a year-over-year increase of 25.12%, and a net profit of 1.648 billion RMB, up 49.47% year-over-year, aligning with previous performance forecasts [1][4]. - The storage industry cycle is on an upward trend, with the company benefiting from rising storage prices, leading to a gross margin of 44.91% in Q4 2025, an increase of 11.74 percentage points year-over-year [1]. - The company is expected to continue its strong growth trajectory in 2026, driven by its niche DRAM, NOR Flash, and SLC NAND businesses, which are projected to see both volume and price increases [1][3]. Summary by Sections Financial Performance - In 2025, the storage business generated 6.566 billion RMB, a 26.41% increase year-over-year, with significant contributions from niche DRAM and SLC NAND due to supply constraints [2]. - The MCU business reported revenue of 1.910 billion RMB, up 12.98% year-over-year, with a 22% increase in sales volume [2]. - The analog chip business saw a remarkable growth of 2052%, with existing products growing approximately 460% year-over-year [2]. 2026 Outlook - The company anticipates continued growth in its DRAM segment, with tight market supply expected to sustain price increases in the first half of 2026 [3]. - Custom storage projects are entering production phases, with expected contributions to revenue from applications in automotive, AI, and robotics [3]. - The company plans to deepen its market presence in automotive, computing, and AI sectors, aiming for volume and price increases [3]. Profit Forecast and Valuation - Revenue projections for 2026, 2027, and 2028 are 19.204 billion RMB, 24.996 billion RMB, and 28.343 billion RMB, respectively, with year-over-year growth rates of 108.66%, 30.16%, and 13.39% [4][9]. - The expected gross margins for the next three years are 47.9%, 38.9%, and 30.7%, with net profits projected at 6.272 billion RMB, 6.148 billion RMB, and 4.791 billion RMB [4][9].

Investment Rating - The report maintains a "Buy" rating for the company [6][4]. Core Views - The company is expected to benefit from a dual performance elasticity in 2026 due to global energy disruptions that may catalyze coal and oil price increases, particularly benefiting from high-calorific Australian coal prices [1]. - The company has a complete coal chemical industry chain, including coal gasification and liquefaction, which is expected to enhance profit margins as the oil-coal price ratio widens [1]. - The company’s coal production is projected to reach 182 million tons in 2025, with a revenue forecast of 176.07 billion yuan in 2026, reflecting a 21.48% year-on-year growth [10]. Financial Performance Summary - In 2025, the company achieved a revenue of 144.93 billion yuan, a decrease of 7.49% year-on-year, with a net profit attributable to shareholders of 8.38 billion yuan, down 43.61% year-on-year [10]. - The average selling price of coal decreased by 20.2% to 517.8 yuan per ton in 2025, while the cost of self-produced coal fell by 4.3% to 321.1 yuan per ton [2]. - The company’s coal chemical segment saw a revenue decline of 5.8% to 24.29 billion yuan, but the gross margin increased by 5.15 percentage points to 26.29% due to cost reductions [2]. Growth Path and Strategic Initiatives - The company has a clear growth path with plans to increase coal production capacity by approximately 70 million tons by the end of the 14th Five-Year Plan [10]. - New projects in coal chemicals, such as the 800,000 tons/year olefin project in Inner Mongolia, are expected to contribute to growth starting in 2026 [10]. - The company is also expanding into non-coal minerals, with significant resources in molybdenum and potassium chloride, which are anticipated to become important profit growth points [10].

Investment Rating - The investment rating for the company is "Buy" with a target price of 8.20 HKD [6]. Core Views - The company reported a revenue of 56.34 billion HKD for the year 2025, a decrease of 3.3% year-on-year, and a net profit of 1.41 billion HKD, down 8.5% year-on-year, which was above expectations due to better-than-expected performance in international freight forwarding [1][4]. - The company is expected to maintain its earnings forecasts for 2026 and 2027, with net profits projected at 1.44 billion HKD and 1.54 billion HKD respectively, and a new forecast for 2028 at 1.62 billion HKD [4]. Summary by Sections Financial Performance - The international freight forwarding business generated revenue of 42.33 billion HKD, down 3.4% year-on-year, with a segment profit of 1.87 billion HKD, down 3.9% year-on-year, primarily due to weak international trade demand [2]. - The comprehensive logistics business reported revenue of 14.01 billion HKD, a decrease of 3.0% year-on-year, with a segment profit of 1.26 billion HKD, an increase of 0.9% year-on-year [3]. Regional Performance - Profit contributions from various regions showed mixed results: Mainland China profit increased by 7.2% to 720 million HKD, while profits from the Americas decreased by 37.4% to 380 million HKD [2]. - The Asia and Oceania markets experienced significant growth, with profits increasing by 22.8% and 36.9% respectively, driven by the shift of manufacturing to Southeast Asia and South Asia [3]. Market Outlook - The company is optimistic about its long-term prospects, particularly in Southeast Asia, where it aims to leverage its diversified logistics solutions to smooth out market fluctuations and demonstrate profit resilience [1][4]. - The ongoing geopolitical uncertainties and tariff policies are expected to impact global macroeconomic and trade demand, but the company remains confident in its strategic positioning [4].

Investment Rating - The investment rating for the company is "Buy" for both A and H shares, maintained from previous assessments [7]. Core Insights - The company achieved a revenue of 14.095 billion RMB in 2025, representing a year-over-year increase of 14.8%, with adjusted non-IFRS net profit reaching 1.816 billion RMB, up 13.0% year-over-year. The performance aligns with the company's earnings forecast, showing a positive acceleration in overall performance [1]. - The company expects a revenue growth of 12%-18% in 2026, driven by a recovery in downstream industry demand and the strengthening of its core laboratory services [1]. - The gross margin for 2025 was 34.8%, an increase of 0.6 percentage points year-over-year, supported by improved performance in key business segments [2]. Summary by Sections Financial Performance - In 2025, the company reported a net cash flow from operating activities of 3.221 billion RMB, reflecting a 25.0% year-over-year improvement [2]. - The company’s expenses for sales, management, and R&D were 2.2%, 12.3%, and 4.1% respectively, with R&D investment being a focus for long-term competitive strength [2]. Laboratory Services - The laboratory services segment generated revenue of 8.159 billion RMB in 2025, a 15.8% increase year-over-year, with over 56% of this revenue coming from biological sciences [3]. - The company is enhancing its flagship business capabilities, expanding into complex new molecular synthesis while applying AI and automation technologies in laboratory chemistry [3]. Other Business Segments - The CMC segment achieved revenue of 3.483 billion RMB in 2025, up 16.5% year-over-year, with a gross margin of 34.3% [4]. - The clinical CRO segment reported revenue of 1.957 billion RMB, a 7.1% increase year-over-year, with expectations for continued positive growth in 2026 [4]. - The large molecule and CGT segment generated revenue of 475 million RMB, also reflecting a 16.5% year-over-year increase, indicating a strengthening of business capabilities [4]. Profit Forecast and Valuation - The company’s net profit forecasts for 2026-2028 are adjusted to 1.933 billion RMB, 2.273 billion RMB, and 2.694 billion RMB respectively, with a target price of 39.98 RMB for A shares and 31.02 HKD for H shares, based on a PE ratio of 38x for A shares and 26x for H shares [5].